CMAX Clinical Research Revenue and Competitors
Estimated Revenue & Valuation
- CMAX Clinical Research's estimated annual revenue is currently $20M per year.
- CMAX Clinical Research's estimated revenue per employee is $104,563
Employee Data
- CMAX Clinical Research has 191 Employees.
- CMAX Clinical Research grew their employee count by 16% last year.
CMAX Clinical Research's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Financial Officer & Company Secretary | Reveal Email/Phone |
2 | Chief Operations Officer | Reveal Email/Phone |
3 | Chief Operating Officer | Reveal Email/Phone |
4 | Finance and Payroll Officer | Reveal Email/Phone |
5 | Recruitment Officer | Reveal Email/Phone |
6 | Participant Engagement Officer | Reveal Email/Phone |
7 | Training Manager | Reveal Email/Phone |
8 | Clinical Project Manager | Reveal Email/Phone |
9 | Study Start-Up Manager | Reveal Email/Phone |
10 | Clinical Services Manager | Reveal Email/Phone |
CMAX Clinical Research Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $20M | 191 | 16% | N/A | N/A |
What Is CMAX Clinical Research?
Established in 1993, CMAX is one of Australia's largest, longest running and most experienced, dedicated clinical trials unit. Our team specialises in a range of early-phase clinical trials, including first-time in human-studies - of which we've conducted more than 100 to date. With an impressive global regulatory history and a database of more than 13,000 active volunteers, our brand new 50-bed Phase I (through to Phase II-IV) unit includes a 24-bed ambulatory cardiac telemetry monitoring system and is centrally located to Adelaide's Bio-med City. All of our studies are fully ICH GCP compliant and comply with the registration requirements of the US FDA, EMEA, Japanese MHW and Canadian HPB; we have been US FDA-audited.
keywords:N/AN/A
Total Funding
191
Number of Employees
$20M
Revenue (est)
16%
Employee Growth %
N/A
Valuation
N/A
Accelerator
CMAX Clinical Research News
Skye Bioscience Engages Clinical Trial Site for Phase 1 Study in Agreement with CMAX Clinical Research. April 28, 2022 07:00 ET | Source: Skye Bioscience,...
This study will be conducted in CMAX's purpose-built independent clinical trial facility in Adelaide, Australia. CMAX is one of Australia's...
Recce Pharmaceuticals Announces Phase I Clinical Trial of RECCE® 327 ... study being conducted at Adelaide's CMAX clinical trial facility.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $46M | 191 | 15% | N/A |
#2 | $76.7M | 192 | 2% | N/A |
#3 | $70M | 194 | 6% | N/A |
#4 | $64.7M | 197 | 6% | N/A |
#5 | $46.4M | 198 | 23% | N/A |